Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - TOTAL CURRENT LIABILITIES
Total Current Liabilities CHRS - Coherus BioSciences, Inc.
332 M
LAST VALUE
104.90%
2 YEAR CAGR
58.41%
5 YEAR CAGR
19.97%
10 YEAR CAGR